“…77 In contrast, SPECT MPI has been shown to be a cost-effective tool in the early detection of ischemic heart disease in patients with chest pain, contributing substantially to their risk stratification. 56 When used for acute chest pain syndromes, costeffectiveness of rest SPECT MPI has been shown in several studies 27,67,72,78 including a controlled, multicenter trial with true cost data. 21 Similarly, dobutamine-atropine echocardiography 70 as well as contrast echocardiography 65,79 have both been shown to be cost effective in ED patients by reducing admissions, length of stay, and downstream resource utilization.…”